CLINICAL_TRIALS
trial_result
· 2007-07-06
Clinical Trial Update: Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters) [Phase 2]
Summary
A Phase 2 trial evaluated growth hormone as add-on therapy in adults with severe fibromyalgia and low IGF-1, and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centro Medico Teknon | Conditions: Fibromyalgia, Growth Hormone Deficiency | Phase 2 | Status: COMPLETED